Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Search Library Posts Search

New Indication: Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-5-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma

New Indication: Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-5-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma
Study:
  • A Phase III Multi-center, Randomized, Open-label trial
  • Untreated non-keratinizing, stage T1-T4 N2-N3 M0 nasopharyngeal carcinoma
  • Chemoradiotherapy followed by Gemcitabine + Cisplatin (n=120) vs Chemoradiotherapy followed by Cisplatin + 5-Fluorouracil (n=120)
Efficacy:
  • 3-year PFS: 83.9% vs. 71.5%, HR:0.54, p=0.023
Safety:
  • Grade≥3: leukopenia (52% vs.29%), neutropenia (32% vs.16%), anemia (20% vs.14%), nausea (20% vs.13%), mucositis (24% vs.28%)

Lancet Oncol, VOLUME 24, ISSUE 7, P798-810, JUL 2023

Liu Li-Ting J et al. Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-5-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: A multicentre, open-label, randomized, controlled, phase 3 trial.

http://doi.org/10.1016/S1470-2045(23)00232-2

Reviewed by Elvin CHALABİYEV, MD on JUL 10, 2023

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More